COMPARISON OF THE PERFORMANCE OF SB2‐INFLIXIMAB WITH ORIGINATOR INFLIXIMAB IN THE MEASUREMENT OF CONCENTRATIONS IN SERUM
Latest Information Update: 13 May 2022
At a glance
- Drugs Infliximab (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Pharmacokinetics
- 16 Oct 2017 New trial record